Directory

>

Kathryn Packman

avatar

Kathryn Packman

Compound Development Leader | The Janssen Pharmaceutical Companies of Johnson & Johnson

Newton, Massachusetts, United States

View contact details (it's free)

Kathryn Packman

Summary

Kathryn Packman is a seasoned Clinical and Preclinical Oncology Research and Development Leader with over 20 years of experience in drug discovery and pharmacology. She has a proven track record of leading teams that have successfully delivered more than 30 drugs to clinical stages. With extensive expertise in both small and large molecule drug development, she is known for integrating cutting-edge technologies to enhance preclinical data packages. Kathryn's leadership experience spans various roles at Johnson & Johnson, where she has shaped research project portfolio strategies. Additionally, she serves on the Industry Advisory Board of the Harper Cancer Research Institute, showcasing her commitment to collaborative research. Her academic background includes a Ph.D. in Cell and Molecular Biology from the University of Notre Dame, underscoring her solid foundation in scientific research. Kathryn’s interests lie at the intersection of oncology innovation and translational medicine, making her a valuable asset in the pharmaceutical industry.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Non-Profit Experience

Kathryn Packman

Work Experience

company logo

Compound Development Leader at

The Janssen Pharmaceutical Companies of Johnson & Johnson

January 2021 - Present

company logo

Industry Advisory Board Member at

Harper Cancer Research Institute

January 2017 - Present

company logo

Global Head of Tumor Biology at

The Janssen Pharmaceutical Companies of Johnson & Johnson

September 2015 - June 2023

company logo

Scientific Director Oncology Collaborations at

The Janssen Pharmaceutical Companies of Johnson & Johnson

October 2013 - August 2015

company logo

Head of Preclinical Oncology Research at

ROCHE LEON HOLDINGS

October 2012 - September 2013

company logo

Adjunct Professor at

Rutgers Cancer Institute of New Jersey

January 2003 - January 2013

company logo

Head of Tumor Biology/ In Vivo Pharmacology at

ROCHE PRODUCTS PTY LTD

April 2002 - October 2012

💼

Postdoctoral Fellow at

UNIVERSITY OF NOTRE DAME

January 2000 - January 2002

Logos provided by Logo.dev

Kathryn Packman

Education

SUNY Geneseo, Bs

Frequently Asked Questions about Kathryn Packman

What is Kathryn Packman email address?

Kathryn Packman's primary email address is ********@its.jnj.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Kathryn Packman work for?

Kathryn Packman is a Compound Development Leader at The Janssen Pharmaceutical Companies of Johnson & Johnson, a company specializing in Pharmaceutical & Medicine Manufacturing.

Where Kathryn Packman graduated from?

Kathryn Packman holds a degree in Cell And Molecular Biology from University of Notre Dame.

How can I directly contact Kathryn Packman?

To contact Kathryn Packman directly, you can use the email address ********@its.jnj.com. Complete contact information is available upon registration with Muraena.

Who is Kathryn Packman?

Kathryn Packman is a seasoned Clinical and Preclinical Oncology Research and Development Leader with over 20 years of experience in drug discovery and pharmacology. She has a proven track record of leading teams that have successfully delivered more than 30 drugs to clinical stages. With extensive expertise in both small and large molecule drug development, she is known for integrating cutting-edge technologies to enhance preclinical data packages. Kathryn's leadership experience spans various roles at Johnson & Johnson, where she has shaped research project portfolio strategies. Additionally, she serves on the Industry Advisory Board of the Harper Cancer Research Institute, showcasing her commitment to collaborative research. Her academic background includes a Ph.D. in Cell and Molecular Biology from the University of Notre Dame, underscoring her solid foundation in scientific research. Kathryn’s interests lie at the intersection of oncology innovation and translational medicine, making her a valuable asset in the pharmaceutical industry.

Kathryn`s contact details

mail

********@its.jnj.com

********@janssen.com

Colleagues

avatar
Olav Lyngberg

VP of Innovation and Technology Deployment, Janssen Supply Chain

avatar
Fiona Elwood

VP, Disease Area Stronghold Lead, Neurodegeneration

avatar
Gunaretnam Rajagopal

Venture Partner

Tc Foong

Director IT

avatar
Kiran Patel

Vice President Clinical Development, Solid Tumor Franchise

avatar
Neelesh Shanbhag

CIO & VP of Business Technology

avatar
Stacy Meridieth

Executive Sales Representative

avatar
Erik Holl

Managing Director - the Netherlands

avatar
Ernie Knewitz

Vice President, Communications, The Americas

avatar
Ashish Kohli

Vice President- Global Neuroscience, Infectious Disease, Vaccines and GPH Regulatory Head

View Contact details (it's free)
Request Profile Removal